Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer
NCT02107430
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
BIOLOGICAL:
Dendritic Cells DCVAC/PCa
RADIATION:
Standard radiotherapy
Sponsor
SOTIO a.s.